Human Genome Epidemiology Literature Finder
Records 1 - 5 (of 5 Records) |
Query Trace: Asthma and CYP3A4[original query] |
---|
Pharmacogenetics of the 5-lipoxygenase biosynthetic pathway and variable clinical response to montelukast. Pharmacogenetics and genomics 2007 Mar 17 (3): 189-96. Klotsman Michael, York Timothy P, Pillai Sreekumar G, Vargas-Irwin Cristina, Sharma Sanjay S, van den Oord Edwin J C G, Anderson Wayne |
Fluticasone propionate pharmacogenetics: CYP3A4*22 polymorphism and pediatric asthma control. The Journal of pediatrics 2013 Jan . Stockmann C, Fassl B, Gaedigk R, Nkoy F, Uchida DA, Monson S, Reilly CA, Leeder JS, Yost GS, Ward RM |
Association of matrix metalloproteinase 8 genetic polymorphisms with bronchial asthma in a Japanese population. Allergy & rhinology (Providence, R.I.) 2013 4 (3): e132-9. Shimoda Terufumi, Obase Yasushi, Kishikawa Reiko, Iwanaga Tomoa |
Effects of CYP2C9 genetic polymorphisms on the pharmacokinetics of zafirlukast. Archives of pharmacal research 2016 Jul . Lee Hyun-Jee, Kim Young-Hoon, Kim Se-Hyung, Lee Choong-Min, Yang Ae-Yun, Jang Choon-Gon, Lee Seok-Yong, Bae Jung-Woo, Choi Chang- |
Prevalence, determinants and clinical correlates of vitamin D deficiency in adults with inhaled corticosteroid-treated asthma in London, UK. The Journal of steroid biochemistry and molecular biology 2016 Nov . Jolliffe David A, Kilpin Kate, MacLaughlin Beverley D, Greiller Claire L, Hooper Richard L, Barnes Neil C, Timms Peter M, Rajakulasingam Raj K, Bhowmik Angshu, Choudhury Aklak B, Simcock David E, Hyppönen Elina, Corrigan Christopher J, Walton Robert T, Griffiths Christopher J, Martineau Adrian |
- Page last reviewed:Feb 1, 2024
- Content source: